This document discusses Dengue control programmes in India. It begins with an overview of Dengue as the most common arthropod-borne viral disease affecting urban and peri-urban areas. It then provides details on Dengue virus and clinical syndromes. The majority of the document outlines India's National Vector Borne Disease Control Programme strategies, which include early case detection and treatment, integrated vector management through environmental modification and chemical/biological control, and behavior change communication. Statistics on reported Dengue cases in Maharashtra from 2018 are also presented.
Dengue Control Programme
Dr.Anjali V. Wagh
Professor & Head
Dept.of Community Medicine
D.Y.Patil Medical College, Kolhapur.
2.
• Most commonarthropod borne viral
disease
• One of the most important Emerging
diseases of the tropical & subtropical
regions affecting urban & peri-urban areas.
• Multifaceted epidemiology
Dengue fever
3.
Dengue virus
GroupB arbovirus , genus -flavivirus
There are four serotypes of dengue (1 to 4)
closely related to one another.
Recovery from one serotype provides
lifelong immunity
Sequential infection increases the risk of
more serious disease resulting in DHF.
Serotypes=Genotypes /subtypes
DENV-1 = 3
DENV-2 = 6
DENV-3 = 4
DENV-4 = 5
4.
Pune, 164,15%
Kolhapur,491,45%
Aurangabad,58,5.3%
Nagpur,29, 2.7%
PMC–53
Pune(R) -25
Satara- 28
Solapur(R)– 39
SolapurMC- 18
KolhapurMC– 347
Kolhapur(R)- 92
Sangli- 29
Nashik,154,14.1%
NashikMC- 117
Nashik(R)- 23
Thane,115, 10.5%
Gr.Mumbai - 54
Palghar- 41
Nanded-37
AurangabadMC- 21
Inter-regional variation
may possibly be
attributable to artefacts
including reporting bias
Total Dengue Cases = 1091
Death = 1
Latur, 62, 5.7%
Akola, 18,1.6%
Division wise distribution of dengue
Up to June 2018
5.
Watch out !This Mosquito
• Day biting – Female mosquito normally catches us unaware
• Domestic breeder - urban mosquito
• Breeding habit - artificially collected water in homes
• Resting habit – endophilic , Dark corners of home
• Feeding habit - Anthrophilic
• Nervous feeder ( bite more than one host)
• Discordant species (more than one feed for complete
gonotrophic cycle)
• Transovarian transmission of virus
• Dispersal – 100 mt. only
Aedes aegypti
Aedes albopictus
“Tiger Mosquito”
6.
Breeding habits
Aedes aegypti
•Aedes aegypti mosquito breeds in any type of man made containers or
storage containers having even a small quantity of water
• Eggs of Aedes aegypti can survive without water up to one year. But water
is essential during first 8 days of life of mosquito.
7.
Environmental factors
• Aedesaegypti fluctuates with rain fall & water storage
• Survives best between temp. 16 0 c -30 0 c & Humidity - 60 – 80 %
• Even with 20 c increase in temp., Extrinsic Incubation Period of
DENV will be shortened.
• More infected mosquitos are available for longer duration.
• Because of dehydration mosquito will bite more frequently &
increases man - mosquito contact.
8.
Transmission of dengue
byAedes aegypti
Illness
Mosquito feeds
Acquires virus
Mosquito re-feeds
Transmits virus
Extrinsic
Incubation
period
Intrinsic
Incubation
periodViremia Viremia
Days 0 1612 20 24 285 8
Susceptible HostInfected Host
Illness
Diagnostic Markers ofDengue
Dengue NS 1 antigen Day 1 to 9
Dengue Ig M Day 5 to 21
Dengue Ig G Day 30 +
11.
NVBDCP – Denguecontrol
• Early case detection and treatment
• Strengthening referral services
• Epidemic preparedness and rapid response
Disease
management
• Entomological surveillance
• Chemical methods
• Personal protection
• Legislative measures
Integrated vector
management
• Behavior change communication
• Inter-sectoral convergence
• Capacity building
Supportive
interventions
• Source reduction
12.
Dengue case definition
ProbableDF/DHF
• A case compatible with clinical description of dengue fever during outbreak or
• Non ELISA based NS 1antigen/ IgM positive*
Confirmed dengue fever
• A case compatible with the clinical description of dengue with at least one of the following
• Isolation of dengue virus (Virus culture+ VE) from serum, plasma, leucocyte
• Demonstration of IgM antibody by ELISA positive in single serum sample
• Demonstration of dengue virus antigen in serum sample by NS-1 ELISA
• IgG serocnversion in paired sera after 2 weeks with four fiold increase in IgG titer
• Detection of viral nucleic acid by polymerase chain reaction (PCR)
* A positive test by RDT will be considered as probable due to poor sensitivity specificity of currently available RDTs
13.
Treatment of Dengue
•Supportive measures –Antipyretics, oxygen as per need
• Plenty of water and salt are required
• Monitor BP, haematocrit, platelet count, RFT, LFT
• Watch level of consciousness, signs of bleeding
• Avoid Aspirin and pain killers
• Steroids should not be used
• Children below 12 require careful watch for dangerous form
• No antibiotics are of proven value
14.
Key Elements ofIVMIntegrated vector control
Intersectoral
coordination
Environmental Manipulation
& Modification
Biological
control
IEC activities
Personal Protection
measures
Chemical
control
15.
Environmental modification
Removal ofnatural breeding sites
Turn pails and watering cans
over and store them under shelter.
Remove water in plant pot plates. Clean and scrub the
plate thoroughly to remove mosquito eggs. Avoid the use
of plant pot plates, if possible.
Loosen soil from potted plants to prevent
the accumulation of stagnant water on the
surface of the hardened soil.
Cover rarely used gully traps. Replace the
gully trap with non-perforated ones and
install anti-mosquito valves.
16.
Entomological surveillance
Larval Surveys
Houseindex (HI)
• Percentage of houses infected with larvae or pupae
Container Index (CI)
• Percentage of water holding container infected with larvae or pupae
Breteau Index (BI)
• No. of positive containers per 100 houses inspected
Pupae Index (PI)
• No. of pupae per 100 houses inspected
• AnHI>5%&/or a BI>20for anylocality isan indication that the locality isdengue
sensitive and therefore adequate preventive measures should betaken
17.
Entomological surveillance
Adult Surveys
Landing/bitingcollection
• Presence of aedes aegypti mosquito can be reliable indicator of clear proximity to hidden larvae
habitats
• It is expressed as landing/ biting counts per man hour.
Resting collection
• Mosquitoes typically rest indoors, especially in bedrooms and mostly in dark places, such as cloth
closets and other sheltered sites
• Mosquito searched with the aid of flashlight & Recorded as number of adults per house per man
hour of human efforts
Oviposition traps
• Ovitraps are devices used to detect presence of Aedes aegypti where population density is low
(BI < 5) (urban areas)
• Used to evaluate impact of adulticidal space spraying on female adult mosquito population
18.
Vector control
Chemical control
Larvicide
•Temephos - (50 EC) 1ppm (1mg per lit. of water)
Adulticide
• e.g. Malathion fogging or ULV spray
• Pyrethrum spray ( 0.1%-o.2%) – Indoor spray
(30-60 ml /1000 cu. ft.)
• Commercial spray – 2% pyrethrum is diluted by kerosene
into 20 lit. to make o.1% formulation.
Repellents
• DEET, indalone, diethyl benzamide, dimethyl phathalate.
19.
Larvivorous Fish
Gambusia
affinis
Lebister
reticulatus
Aphanius
dispar
Mosquitolarvae are typically good source of food
for organisms such as the
Larvae-eating fish(e.g. Gambusia “mosquito
fish”),
Immature dragonflies and damselflies,
Aquatic beetles, and
Certain aquatic organisms such as planaria
Endotoxin producing bacteria
Bacillus thuringiensis iserailensis (Bti)
Biological control
20.
Vector control
Genetic control
Methodssuch as
1. Sterile male technique
2. Cytoplasmic incompatability
3. Chromosomal translocations
4. Sex distortion
5. Gene replacement
Limitations:
1. Lack ofmating competitiveness released males.
2. Immigration of fertile females from regions close to the release sites.
21.
Repellants
Personal protection
a) Mosquitonet: ITBN treated with
Deltamethrin
b) Screening: of windows, not >0.0475 inch in
any diameter.
c) Repellants : DEET, indalone, diethyl
benzamide, dimethyl phathalate.
Bednet hole size :
Not bigger than 1.2 to 1.5 mm. diameter.
i.e. 6 to 8 holes to 10 mm. linear length.
Dosage :
25 mg Deltamethrin / sq. mt.
OR
50 mg Cyfluthrin / sq. mt.
22.
Behavioral change communicationcampaign
Massive, Repetative, Intense and Persistent
Educate public on – Transmission of disease, mosquito
breeding sites, symptoms of Dengue, vector control measures.
Mass media - T.V., Radio, Newspapers, cable etc.
Outdoor publicity – Hoardings, miking, rallies
Health education material distributed –pamphlets, handbills.
Interpersonal communication – group meetings, folk media
Involvement of VHSC, ASHA
Inter-sectoral Collaboration & community participationis the key
components for prevention and control of Dengue
23.
Mosquito abatement
Weekly scheduleofsocialmobilization- Satara
No. Activity Periodicity Responsibility
1 Gramsabha, Fever Surveillance Monday THO/BDO/MO/
2
Dry day, Container surveillance,
distribution of pamphlets
Tuesday
Gramsevak, HA, MPW
(M/F), Aanganwadi sevika
3 Removal of tires and mesh for ventpipe Wednesday Headmasters,
4
Application of Temephos , Introduction
of guppy fish in cementcontainers
Thursday Teachers, ASHA
5 Sanitization, miking Friday
6 Student march Saturday
24.
Model civic by-laws:
• Fine / punishment is imparted, if breeding is detected.
Strictly imposed by Mumbai, Navi Mumbai, Chandigarh and
Delhi Municipal Corporations.
Building construction regulation act :
• For overhead / underground tanks etc In Mumbai, builders
deposit a fee for controlling mosquitogenic conditions at site
Environmental Health Act :
• By-laws for proper disposal / storage of junk, discarded tins
old tyres and other debris
Health Impact Assessments :
• Prior to any development projects/major constructions
Legislative measures
25.
The World MosquitoProgram’s Wolbachiamethod
Release of either all mosquitoes or male only mosquitoes with Wolbachia
WMP and ICMR partnership is researching at Puducherry through VRC(2016-17)
Modified Vector
density and
vector competence
26.
Dengue vaccine
CYD-TDVdeveloped by Sanofi
Pasteur is a recombinant
tetravalent (four-serotype) live
attenuated virus vaccine that
was first licensed in Mexico in
December 2015.
It took Sanofi-Pasteur about 20
years to design and improve the
Dengvaxia.
Useful in individuals 9–45 years of age living in endemic areas.
It is given as a three-dose series on a 0-, 6-, 12-month schedule.
Additional dengue vaccine candidates are in clinical development.
27.
Dengue vaccines indevelopment
Vaccine type Component Dose Frequency Country
NIH vaccine
TV003/TV005
Live
attenuated
tetravalent
One
component is
a chimeric
virus
Single dose 74-92% (TV003)
and 90% (TV005)
of flavivirus-naïve
licensed to Instituto
Butantan (Brazil),
Vabiotech (Viet Nam),
Panacea Biotech &
Serum Institute (India)
TDV - Takeda Based on Den
2
Chimeric
virus
Two doses 3 months Takeda Japan
GSK - PIDV Purified
inactivated
tetravalent
Two doses 28 days U.S. and Puerto Rico
Merck-Vaccine Sub-unit
protein
truncated
envelope
protein (E)
Three doses 1 month apart Australia
28.
Global strategy forDengue prevention & control
( 2012 - 2020)
Dengue has global threat that require global response.
Coordination & collaboration among multi-sectoral partners on
Integrated vector management approach
Goals –
1) To reduce mortality by at least 50 % by 2020
2) To reduce morbidity by at least 25 % by 2020
3) To estimate true burden of the disease by 2015
29.
Take home message….
DHFas a serious Public Health Problem
Early diagnosis and treatment of cases
Stop spread of disease
• Passive surveillance • Active surveillance
Elimination of breeding places of mosquito.
• Used tyres, bottles and containers should be disposed of properly.
Personal protection:
• Use of mosquito nets, repellant creams, mosquito coils, mats and
aerosols.
Health education